ABSTRACT Key to the virulence of apicomplexan parasites is their ability to move through tissue and to invade and egress from host cells. Apicomplexan motility requires the activity of the glideosome, a multicomponent molecular motor composed of a type XIV myosin, MyoA. Here we identify a novel glideosome component, essential light chain 2 (ELC2), and functionally characterize the two essential light chains (ELC1 and ELC2) of MyoA in Toxoplasma. We show that these proteins are functionally redundant but are important for invasion, egress, and motility. Molecular simulations of the MyoA lever arm identify a role for Ca 2؉ in promoting intermolecular contacts between the ELCs and the adjacent MLC1 light chain to stabilize this domain. Using point mutations predicted to ablate either the interaction with Ca 2؉ or the interface between the two light chains, we demonstrate their contribution to the quality, displacement, and speed of gliding Toxoplasma parasites. Our work therefore delineates the importance of the MyoA lever arm and highlights a mechanism by which this domain could be stabilized in order to promote invasion, egress, and gliding motility in apicomplexan parasites.
IMPORTANCE
Tissue dissemination and host cell invasion by apicomplexan parasites such as Toxoplasma are pivotal to their pathogenesis. Central to these processes is gliding motility, which is driven by an actomyosin motor, the MyoA glideosome. Others have demonstrated the importance of the MyoA glideosome for parasite motility and virulence in mice. Disruption of its function may therefore have therapeutic potential, and yet a deeper mechanistic understanding of how it works is required. Ca 2؉ -dependent and -independent phosphorylation and the direct binding of Ca 2؉ to the essential light chain have been implicated in the regulation of MyoA activity. Here we identify a second essential light chain of MyoA and demonstrate the importance of both to Toxoplasma motility. We also investigate the role of Ca 2؉ and the MyoA regulatory site in parasite motility and identify a potential mechanism whereby binding of a divalent cation to the essential light chains could stabilize the myosin to allow productive movement.
proteins GAP40 and GAP50 and members of the GAPM family (3, 5, 6) , while GAP45 acts as a molecular tether between the IMC and the PM, maintaining a critical distance between the two membrane systems (3) . MyoA then attaches to the GAP complex courtesy of a unique N-terminal extension on its regulatory light chain (RLC), MLC1 (Plasmodium myosin A tail-interacting protein [MTIP] homologue) (3, 7, 8) . In order to move with respect to the host environment, transmembrane adhesins displayed on the surface of parasites are thought to link to the glideosome through their short cytoplasmic tails. Previous evidence suggested that the glycolytic enzyme aldolase may act as a bridge between the cytoplasmic tails of adhesins and the actin filaments (9, 10) and allowed the proposal of a model that suggested that MyoA activity and actin treadmilling drag transmembrane adhesins through the plasma membrane rearward, which in turn drives forward parasite motion. Recent evidence, however, suggests that aldolase is likely not an actin-adhensin bridging protein and there may be some differences between the motor that drives invasion and that which drives tissue dissemination and that this linear model is an oversimplification of how the glideosome functions (11) (12) (13) .
Despite this basic molecular understanding of motility, the mechanisms that regulate the activity of MyoA and how this complex generates force remain largely unknown. In other systems, myosins are usually made up of head, neck, and tail domains. The head domain hydrolyzes ATP, amplifying small changes in the active pocket, which leads to a large conformational change in the converter domain, allowing pivoting against the lever arm. The myosin lever arm consists of the myosin neck region in association with regulatory light chains (analogous to Toxoplasma MLC1), essential light chains (ELCs), or calmodulins (CaM). The lever arm is also often a regulatory site, where direct interactions with Ca 2ϩ or with Ca 2ϩ -dependent phosphorylation events can modulate motor activity (14) (15) (16) (17) (18) . While MyoA has been shown to be a fast, single-headed plus-end-directed motor (7), little evidence exists on how this unique myosin is activated by the signaling events that are known to regulate motility. MyoA and MLC1 have been shown to be phosphorylated upon activation of motility (19) (20) (21) , and yet subsequent functional studies demonstrated that this posttranslational modification has little to no role in its activation (22, 23) . Furthermore, until recently, only a single light chain-MLC1-was known to exist, thus limiting the possibilities for investigating motor regulation by the lever arm.
Here we identify a novel essential light chain (ELC2) and describe the function of this and the previously identified ELC1 of Toxoplasma MyoA, thus defining the full lever arm of this important molecular motor. We show that ELC1 binds Ca 2ϩ and use structural modeling and molecular dynamics in combination with functional studies to show that key residues predicted to coordinate an interaction interface between ELC1 and MLC1, mediated by Ca 2ϩ , can affect the quality, speed, and displacement of parasites as they move across a substrate. Our work therefore provides the first insight into how the MyoA lever arm is stabilized in order to provide structural rigidity for force generation during the motility of apicomplexan parasites.
RESULTS
Toxoplasma ELC2 associates with the glideosome. Previously, we identified a potential essential light chain (ELC1) of the Toxoplasma glideosome using quantitative proteomic techniques (19) . Upon further interrogation of the remaining hypothetical proteins detected in the same experiment, we identified a second calmodulin-like protein (TGME49_305050) with a predicted mass of 15 kDa, four putative EF hands (EFs) (Ca 2ϩ binding regions), and 68% protein sequence similarity to ELC1. The striking similarities suggested to us that TGME49_305050 may be a second essential light chain (ELC2) and prompted us to investigate its potential association with the glideosome.
To determine the localization and potential interaction of ELC2 with the glideosome, we genetically fused a triplehemagglutinin (HA 3 ) epitope tag to the C terminus of this protein at the endogenous locus and performed immunofluorescence and coimmunoprecipitation (Co-IP)-Western blot analyses of ELC2-HA-expressing parasites (Fig. 1) . Expression of ELC2-HA was confirmed by Western blotting and compared to expression of parental (RH⌬HX) and ELC1-HA-expressing parasites (Fig. 1A ) (19) . Probing with anti-HA antibodies detected a protein of 18 kDa in ELC2-HA lysate comparable to ELC1-HA at 17 kDa, whereas nothing was detected in the parental control (Fig. 1A , left panel). Antibodies raised to recombinant ELC1 revealed a single 15-kDa protein in parental and ELC2-HA-expressing parasites but only a higher band (17 kDa), corresponding to the HA-tagged version of ELC1, in ELC1-HA parasites, thus confirming that anti-ELC1 antibodies do not cross-react with ELC2 (Fig. 1A , right panel). Immunofluorescence microscopy of intracellular parasites expressing ELC2-HA showed that this protein resides at the parasite periphery and colocalizes with staining by anti-GAP45 antibodies (Fig. 1B, bottom panel) . The localization observed was very similar to that observed from parasites expressing ELC1-HA (Fig. 1B, top panel) and was thus consistent with ELC2 being a component of the glideosome. We then performed Co-IP of ELC2-HA lysate with anti-HA to formally establish the interaction of this protein with various components of the Toxoplasma glideosome. Upon probing of IP eluates of parental, ELC1-HA (positive control), and ELC2-HA parasites with antibodies against the MyoA glideosome, we determined that ELC2 specifically interacts with glideosome components MyoA, GAP45, and MLC1 (Fig. 1C) . Interestingly, antibodies to ELC1 did not detect a signal from the ELC2-HA IP, demonstrating that ELC1 and ELC2 (ELC1/2) do not exist within the same glideosome complexes and therefore likely compete for the same binding site (Fig. 1C ). To further demonstrate the specificity of the interaction between ELC2 and the glideosome, we performed a reciprocal IP with anti-GAP45 antibodies and demonstrated that ELC1-HA and ELC2-HA were copurified but that they were not copurified when normal rabbit (nonspecific) serum (NS) was used (Fig. 1D) . Taken together, these results show that ELC2 is a novel component of the Toxoplasma MyoA glideosome which interacts in a mutually exclusive manner with ELC1.
ELC1 and ELC2 interact with the MyoA neck and, together with MLC1, define the lever arm. The interaction of an essential light chain with its myosin heavy chain occurs at the myosin neck. The complex that they form, together with other regulatory light chains (analogous to Toxoplasma MLC1) or CaM proteins, defines the myosin lever arm, which forms a stable structure for the myosin head to pivot against to create force (24). Recently, Bookwalter et al. showed that ELC1 forms a complex with MyoA upon coexpression using the baculovirus/Sf9 insect cell expression system and that this interaction increased the speed at which MyoA moved actin filaments (25) . To specifically determine if ELC1 and ELC2 interact with the neck of MyoA, we first defined this region to be the last 61 amino acids of MyoA (amino acids 770 to 831), where residues 770 to 799 and 800 to 831 contained the putative ELC and MLC1 binding sites, respectively ( Fig. 2A) . To investigate this we generated transgenic versions of the MyoA neck fused to the FKBPderived destabilization domain (DD) (26) and an Ty epitope tag (27) for the full neck region (DDTyMyoA 770 -831 ) or a truncation lacking the putative ELC binding region (DDTyMyoA 800 -831 ) (Fig. 2B) . These constructs were transiently introduced into ⌬MyoA Toxoplasma parasites (13) and analyzed for size by Western blotting with anti-Ty antibodies. The bands were predicted to be~20 kDa (DDTyMyoA 770--831 ) and~16.5 kDa (DDTyMyoA 800 -831 ) but ran higher (~25 kDa and 20 kDa, respectively), likely due to hydrophobicity. The localizations of ELC1, MLC1, and GAP45 were examined by immunofluorescence microscopy (Fig. 2D) . Consistent with our model, and in agreement with previous data (13), the absence of MyoA had no effect on the targeting of GAP45 or MLC1 to the pellicle. However, peripheral localization of ELC1 was lost and replaced with speckled, cytosolic staining, confirming that MyoA is required to target this CaM-like protein to the parasite periphery (Fig. 2D, upper panel) . Expression of the full MyoA neck (DDTyMyoA 770 -831 ) rescued the localization of ELC1 (Fig. 2D, middle panel) , but expression of a truncated MyoA neck lacking the predicted ELC binding site (DDTyMyoA 800 -831 ) did not (Fig. 2D, bottom panel) .
To confirm these findings, we then heterologously expressed ELC1, ELC2, and the MyoA neck region in Escherichia coli and tested their capacity to interact in vitro by gel filtration chromatography (Fig. 2E) . A shift in the retention time was observed for both ELC1 and ELC2 preincubated with MyoA 770 -831 compared to the results seen with the individual components alone (Fig. 2E , panels i and ii). These results suggest that both ELC1 and ELC2 interact specifically with the MyoA neck, requiring the residues between 770 and 799 and thus defining the lever arm of the MyoA glideosome. Furthermore, this also indicates that ELC1 and ELC2 bind to the same region of MyoA.
The IQ motif is a highly basic sequence of approximately 23 amino acids, with a conserved core that usually fits the consensus sequence IQXXXRGXXXR/K. A very degenerate IQ motif is present downstream from the MLC1 binding site ( Fig. 2A) . Refinement of the structural model presented previously (19) using molecular dynamics favors interaction of ELC1 with residues 782 to 792 (LVSVLEAYYAG) of MyoA (Fig. 2F) . To test this prediction, a full-length His-StrepII-Flag (HSF)-tagged copy of MyoA (HFS-MyoA) was complemented into ⌬MyoA parasites (13) and 3 key hydrophobic residues (L782, L786, and Y790) within the predicted ELC binding site were mutated to alanine to create HSFMyoA-LLY/AAA (Fig. 2G) . Widefield fluorescence microscopy was performed on ⌬MyoA parasites that were complemented with wild-type HSF-MyoA or mutant HSF-MyoA-LLY/AAA. While staining with anti-Flag showed peripheral localization for both wild-type MyoA and mutant MyoA, anti-ELC1 antibodies detected peripheral staining in wild-type-complemented parasites only and speckled cytosolic staining in mutant-complemented parasites (Fig. 2H) , suggesting that the 3 hydrophobic residues tested are important for ELC1 binding. Despite several attempts, parasites stably expressing HSF-MyoA-LLY/AAA could not be isolated for testing of the functional significance of disrupting this interaction. It is worth noting that removal of MyoA or disruption of the interaction between MyoA and ELC1 led to a speckled rather than diffuse distribution of ELC1 (Fig. 2D , top and bottom panels). The possibility cannot be ruled out that disruption of its interaction with MyoA may cause misfolding of ELC1 and, consequently, mislocalization to inclusion bodies; however, the in vitro data support the conclusion of the presence of a specific interaction between the MyoA neck and ELC1. A single essential light chain (ELC1 or ELC2) is required for efficient Toxoplasma invasion and egress. To determine the importance of ELC1 and ELC2, conditional knockout (cKO) lines were generated by replacing the endogenous promoter of ELC1 or ELC2 with an anhydrotetracycline (ATc)-regulatable promoter in the ⌬Ku80:TATi strain (28, 29) (Fig. 3A , panel i). In addition, N-terminal triple-HA tags were inserted, creating the cKO-HA 3 -ELC1 and cKO-HA 3 -ELC2 parasite lines (referred to here as cKO-ELC1 and cKO-ELC2). Regulation of the loci was assayed by growing parasites for 48 or 96 h in the presence of 1.0 g/ml ATc. Western blot analysis performed with anti-HA demonstrated the progressive loss of ELC expression in both cKO-ELC1 and cKO-ELC2 parasites (Fig. 3B ). Probing with anti-ELC1 antibodies demonstrated the absence of cross talk in expression of the two light chains, and antibodies to Toxoplasma catalase were used as a loading control (Fig. 3B ). Wide-field fluorescence microscopy of intracellular cKO-ELC1 and cKO-ELC2 parasites following ATc treatment confirmed the absence of ELC1 and ELC2, respectively (Fig. 3C) .
To assess the function of ELC1 and ELC2, we assayed the ability of mutant parasite lines to invade and egress host cells. Following growth for 96 h in the presence of ATc, cKO-ELC1 and cKO-ELC2 parasites invaded and egressed normally compared to untreated and wild-type control parasites ( Fig. 3D and E).
To investigate potential functional redundancy of the ELCs, we next used double-crossover homologous recombination to delete ELC1 in the cKO-ELC2 line to derive a conditional double-KO line (cDKO-ELC) (Fig. 3A, panel ii) . In contrast to single-cKO lines, ATc treatment of cDKO-ELC parasites reduced their ability to invade host cells to 10% of that of the wild type (Fig. 3D) . Furthermore, the capacity of parasites to egress in response to stimulation for 2.5 min with the Ca 2ϩ A23187 ionophore was severely attenuated (Fig. 3E ). ATc-treated cDKO-ELC parasites were then complemented by transfection with ectopic DDTytagged ELC1 or ELC2. Stabilization of DDTyELC1 or DDTyELC2 with Shld-1 fully restored the invasion and egress capabilities of the mutant parasites ( Fig. 3D and E), thus highlighting that ELC1 and ELC2 are functionally redundant in their roles as the essential light chain(s) of MyoA during Toxoplasma egress and invasion.
ELC1 and ELC2 are required for the stability of MyoA. As a first step to determining the function of ELC1 and ELC2 in the glideosome, we investigated the assembly of the glideosome in their absence. The data presented in Fig. 2D demonstrate that MyoA is required for correct localization of ELC1. We then tested the reciprocal effect of ELC depletion on the assembly and stability of MyoA at the pellicle. To do this, MyoA was N-terminally tagged by double homologous recombination with a His-Flag-StrepII (HFS) tag in cDKO-ELC parasites and the localization of HFSMyoA was observed after ELC depletion by ATc. Unexpectedly, microscopy of intracellular parasites probed with anti-Flag tag antibodies detected greatly diminished levels of HFS-MyoA after treatment with ATc (Fig. 4A) . In contrast, anti-MLC1 antibodies stained MLC1 at the periphery of parasites in both the presence and absence of ELC. Interestingly, a secondary localization of MLC1 was prominent upon suppression of ELC, where an apparent intracellular structure was marked. This mislocalization is possibly a cellular response specific to the absence of ELC. Further investigation by Western blotting showed that depletion of MyoA is concomitant with the depletion of both ELCs but not of either alone (Fig. 4B ), suggesting that MyoA stability is tightly coupled to ELC function.
Ca 2؉ interacts with ELC1 and potentially causes an intermolecular interaction between ELC1 and MLC1. To better understand the role of the ELCs in the function of the MyoA lever arm, in the absence of a crystal structure, we turned to structural modeling. Previously, we presented a homology model of the lever arm complex (MyoA neck-ELC1-MLC1) based on the solved structure of the scallop myosin II lever arm complex (19) . Here, we extended this model to the complete MyoA protein and performed molecular dynamics for refinement. The MyoA head has a nucleotide-binding pocket, so by inclusion of the full-length MyoA protein we were able to model the complex in various states of its duty cycle. First, ADP was introduced in the nucleotidebinding site and Ca 2ϩ included at ELC1 EF hand I (EFI), similarly to that seen with scallop myosin II. The model predicted Ca 2ϩ to be coordinated by the side chains of ELC1 residues D15, D17, and D19 (Fig. 5A) . The binding affinity of Ca 2ϩ was estimated by performing pulling simulations of Ca 2ϩ from EFI to calculate the change in free energy (⌬G), which was determined to be 79.0 kJ/ mol (data not shown). Furthermore, ELC1 EFI was predicted to interact with MLC1 by backbone hydrogen bonds between ELC1-D17 and MLC1-E179 (Fig. 5A ). This interaction between the two light chains was analyzed by molecular dynamics simulations, The genetic strategy used to create ELC1 and ELC2 conditional knockouts. The endogenous promoter of ELC1 and ELC2 was replaced with 7 Tet operating sequences and the SAG4 minimal promoter (T7S4) in ⌬Ku80:TATi parasites (29) . A HA 3 epitope tag was inserted at the N terminus of ELC1 and ELC2, and transformants were selected for the dhfr gene. In the absence of anhydrotetracycline (ATc), the Tet transactivator (TATi) drives transcription of ELC1/2. In the presence of ATc, transcription is switched off. (ii) The genetic strategy used to create ELC1 and ELC2 double-knockout parasites. The elc1 ORF was replaced with cat to confer chloramphenicol resistance in cKO-ELC2 parasites. (B) Western blot analysis of lysate from ⌬Ku80:TATi, cKO-ELC1, cKO-ELC2, and cDKO-ELC parasites following treatment with 1.0 g/ml ATc. Lysates were probed with mouse anti-HA, rabbit anti-ELC1, and anti-catalase as a loading control. (C) Immunofluorescence analysis of intracellular cKO-ELC1 and cKO-ELC2 parasites grown in the presence and absence of 1.0 g/ml ATc for 96 h. DAPI, 4=,6-diamidino-2-phenylindole. (D) Two-color invasion assay performed on parasites grown with or without ATc for 96 h. DDTy-ELC1 and DDTy-ELC2 expression was stabilized by 1.0 M Shld-1 at~10 h prior to invasion. Numbers of invaded and total parasites were counted from Ͼ5 fields per slide. (E) Fixed-egress assay performed on intracellular vacuoles grown for 30 h prior to stimulation with 8 M A23187. More than 100 vacuoles were counted for each slide. In panels D and E, duplicate or triplicate slides were counted per experiment. Column data represent mean percentage results from 3 independent experiments. Error bars represent Ϯ SEM. and, interestingly, it was only in simulations when Ca 2ϩ was included at EFI that a stable interaction formed between the two light chains, as measured by the distance between the interacting residues ( Fig. 5B ; see also Video S1 and Video S2 in the supplemental material). The functional redundancy between ELC1 and ELC2 suggests that key features and residues that contribute to their role in the MyoA lever arm are likely conserved. To investigate the molecular basis for redundancy, we also generated a structural model in which ELC1 was replaced with ELC2 ( Fig. 5C ). Residues D15 and D19 are conserved between the two essential light chains (ELC2 residues D16 and D20). The only difference around the Ca 2ϩ binding pocket is found in residue 17/18, which is an aspartate in ELC1 and an asparagine in ELC2. This does not imply a large difference regarding the Ca 2ϩ binding. The interaction between ELC1/2 and MLC1 is not affected either, as it is mediated by backbone interactions (Fig. 5A) . Furthermore, when ADP was replaced by ATP at the nucleotide-binding site, a large conformational change, driven by the bending of the MyoA lever arm (see Fig. 5D in comparison to 5A [green] ), changed the relative orientations of the two light chains, and both ELC1-R8 and ELC2-R9 moved into close proximity to the MLC1 backbone (Fig. 5D) .
To test these predictions in vitro, we cloned ELC1 into an E. coli expression vector and introduced several different mutations to assess their effect on Ca 2ϩ binding. We chose to mutate D15 to alanine, as this mutation was predicted to ablate Ca 2ϩ binding at EFI (data not shown). To assess the ELC1-MLC1 interaction in the MyoA-ATP state, we mutated ELC1 R8 to alanine, which was predicted to disrupt the interaction but not affect Ca 2ϩ binding to EFI. Mutant versions of ELC1 were then expressed and purified from E. coli in the same manner as with the wild type.
The interaction of ELC1 and Ca 2ϩ was studied using a thermal shift assay. Sypro-Orange fluorescent dye emits fluorescence upon binding hydrophobic regions. Therefore, as the hydrophobic regions of proteins are exposed when the temperature is increased and the proteins denature, the level of fluorescence emitted also increases. A thermal denaturation curve is obtained by measuring absorbance over time. Because the thermal stability of a protein changes upon binding of an ion such as Ca 2ϩ , this assay was able to detect a potential interaction between ELC1 and Ca 2ϩ by comparing the effects of temperature on absorbance in the presence of either EGTA or Ca 2ϩ . We performed thermal shift assays on wildtype ELC1 and on R8A and D15A mutants in the presence of either Ca 2ϩ or EGTA (Fig. 5E , panels i to iii). As predicted, a shift in the thermal denaturation curve of ELC1 was seen in the presence of Ca 2ϩ compared to EGTA, indicating that an interaction occurred (Fig. 5E, panel i) . Similarly, a shift between curves when ELC1-R8A was tested showed that this mutation did not affect Ca 2ϩ binding (Fig. 5E, panel iii) . In contrast, little to no change in the curve was observed for the ELC1-D15A mutant, suggesting that this mutation was sufficient to disrupt Ca 2ϩ binding and therefore that EFI is likely the only functional Ca 2ϩ binding site on recombinant ELC1 (Fig. 5E, panel ii) . We next determined the affinities of ELC1 and R8A for Ca 2ϩ to be 37 (Ϯ9) M and 43 (Ϯ10) M, respectively, further suggesting that the R8A mutation did not affect Ca 2ϩ binding (Fig. 5F , panels i and ii).
Molecular dissection of predicted MyoA lever arm interactions during Toxoplasma infectivity. Given our modeling and in vitro data described above, we hypothesized that Ca 2ϩ binding to ELC1/2 and the subsequent interaction between ELC1/2 and MLC1 that our modeling data predicted would stabilize the MyoA lever arm to provide a rigid structure against which the head domain could pivot to perform a power stroke for productive Toxoplasma invasion, egress, and motility. In order to investigate this functionally, we created point mutations in either ELC1 or MLC1 and used these to complement conditional KO strains (Fig. 6) . We stably transfected cDKO-ELC parasites with an ectopic version of wild-type ELC1 (DDTy-ELC1) and mutant form R8A or D15A described above (Fig. 6A) . Expression of the mutant and wild-type versions of DDTy-ELC1 was evaluated after growing the parasites in the presence of ATc (as described earlier) and Shld-1 for 10 h followed by immunofluorescence microscopy. Staining of intracellular parasites with anti-Ty antibodies revealed expression and peripheral localization of DDTy-ELC1, R8A, and D15A, suggesting that none of the mutations studied affected localization or, therefore, their association with the glideosome (Fig. 6B) .
As a first step to determine the effect of each mutation on parasite processes, we assessed the ability of intracellular vacuoles to egress when stimulated with Ca 2ϩ ionophore A23187 for 2.5 min before fixing and examining were performed. While the expression of wild-type DDTy-ELC1 rescued the egress block observed for ATc-treated cDKO-ELC parasites, expression of mutants R8A and D15A restored egress only partially (Fig. 6C) . Similarly, expression of the mutants in ATc-treated (Fig. 6D) .
As we were unable to test the predicted interaction between ELC1 and MLC1 in the ADP-bound state by mutating ELC1, given that the interaction involves the ELC1 backbone, we instead investigated this interaction by mutating MLC1 residues. MLC1-E179 is predicted to form a hydrogen bond with the ELC1 and ELC2 backbones (Fig. 5A and C ). An earlier iteration of the structural model also predicted an interaction of MLC1-Y177 with ELC EF1, and yet the refined model shows this residue pointing toward MLC1 itself. For the purpose of comparison, we mutated both these residues. To generate a complementation system for MLC1, we rederived the MLC1 DiCre KO line (loxpMLC1) recently reported (12) and excised the mlc1 gene upon addition of rapamycin (Sigma-Aldrich). We then integrated the wild-type DDTyMLC1 or the Y177A and E179A mutants into the uprt locus of this strain (Fig. 6E) . Expression and localization of the complementing copies of MLC1 were confirmed by immunofluorescence microscopy using anti-Ty antibodies. Peripheral staining of Ty was observed in all lines, and Ty colocalized with anti-GAP45 (Fig. 6F) . Next, loxpMLC1 parasites and DDTyMLC1 mutant and wild-type complemented parasites were treated with 50 M rapamycin 96 h prior to egress to induce deletion of endogenous MLC1. Previously, deletion of MLC1 was reported to cause a complete block of egress (12) . In agreement, we observed egress of only~3.5% of rapamycin-treated loxpMLC1 vacuoles compared to untreated or wild-type controls (Fig. 6G) . Expression of DDTyMLC1 fully restored egress capability and expression of DDTyMLC1 mutants partially restored this ability (Fig. 6G) . The greatest defect in egress was observed when E179 was mutated, resulting in~72% of the level of wild-type egress (Fig. 6G) . As expected, the phenotypic defect in egress upon mutation of Y177 (~83% egress) was not as significant as that seen with mutation of E179 but could have been due to disrupting its interactions with other hydrophobic residues, which may affect the rigidity of the MLC1 loop.
Given the major role that MyoA plays during Toxoplasma motility, we performed an in-depth analysis of parasite movement to more thoroughly understand the role of the ELC1-MLC1 interaction during pathogenicity. Toxoplasma spp. display three main types of motility (circular, twirling, and helical) on a twodimensional (2D) surface, and live video microscopy was used to track and quantify these behaviors in the wild-type line (see Video S3 in the supplemental material) versus the mutant lines (Fig. 7) . Parasites deficient in essential light chains showed only 20% of the gliding frequency of the parental control strain ( Fig. 7A ; see also Video S4). Motile cDKO-ELC parasites were uncoordinated (Video S5) or were limited to a short semicircle of motion (Video S6). Those that did move traveled a short distance only (Fig. 7C ) and were remarkably slow (Fig. 7D) . Parasites expressing ectopic DDTyELC1 showed reconstitution of the motility behaviors and parameters measured ( Fig. 7 ; see also Video S7). Interestingly, however, ELC1 R8A and D15A mutants showed intermediary levels of total motile parasites (Fig. 7A) , as well as a greater frequency of uncoordinated motility and twirling movement, but less helical movement, especially in the D15A mutant (Fig. 7B ) (see Video S8 and Video S9, respectively). On average, those that moved glided shorter distances and at lower speeds such that the R8A mutant showed a greater spread of variability of these parameters than D15A (Fig. 7C and D) .
Recent work has demonstrated that Plasmodium sporozoites move in a stop-and-go fashion, with periods of rapid movement followed by periods of slow movement, which are best quantified by plotting the instantaneous speed versus time (30) . We decided to see if Toxoplasma exhibited the same rhythmic pattern of motility and could be used as a measure of MyoA lever arm function. By plotting of the instantaneous velocity of gliding parasites, we saw that the parental line (⌬Ku80:TATi) displayed oscillating instantaneous speeds, where the velocity reached a maximum of 5 m/s at a frequency of about 3 rounds per 20 s (Fig. 7E, panel  i) . Parasites depleted of both ELCs showed many fewer oscillations with a very low maximal velocity (Fig. 7E, panel ii) . While complementation with wild-type ELC1 resulted in kinetic parameters similar to those seen with the parental lines (Fig. 7E, panel iii) , ELC1 R8A showed a lower peak velocity with the same frequency of bursts of motility (Fig. 7, panel iv) . ELC1 D15A showed the biggest changes in behavior, showing changes in maximal velocity as well as in the frequency of motility oscillations (Fig. 7E, panel v) . Overall, our in-depth analysis shows that the coordination of Ca 2ϩ binding by ELC1 and the interaction between the two light chains of the MyoA lever arm are critical to maintain robust and frequent motility of Toxoplasma across a 2D surface.
DISCUSSION
Gliding motility is critical to the virulence of apicomplexan parasites such as Toxoplasma and Plasmodium spp. (12, 28, 31) . Motility involves the coordinated action of parasite transmembrane adhesins, actin, actin regulators, and the MyoA-based motor termed the glideosome, which generates the force required for motility (32) . The experimental tractability of Toxoplasma, together with advances in genetic techniques, has led to extensive characterization of the glideosome and its components, and yet the mechanisms that regulate its activity and, thus, force production are still unknown. Motility is initiated in response to intracellular Ca 2ϩ signaling events, and reports have shown glideosome components MyoA, MLC1, and GAP45 to be phosphorylated at several sites in a Ca 2ϩ -dependent manner (19) . As many conventional myosins, such as scallop and Physarum myosin II, are regulated by Ca 2ϩ -dependent phosphorylation of the regulatory light chain or direct binding of Ca 2ϩ to the essential light chain (14) (15) (16) (17) (18) , it is possible that the Toxoplasma MyoA lever arm (MyoA neck-light chain complex) is similarly a regulatory site.
We have identified two essential light chains, previously ELC1 (19) and here ELC2, and show that both interact with the MyoA neck in vitro and in vivo. These essential light chains, together with MLC1 and the MyoA neck region, define the lever arm (Fig. 8) , and the data have allowed us to investigate the role of this domain in Toxoplasma gliding motility. In the absence of a structure, we derived a model of the MyoA-ELC1/2-MLC1 complexes using homology modeling and molecular dynamic simulations and identified the region of the MyoA neck where ELC1 and ELC2 bind, and the findings were confirmed by in vivo experiments.
Using the tetracycline conditional-knockout system, we show that ELC1 and ELC2 have redundant roles in the MyoA glideosome but that their shared role is important for all glideosomedependent processes. Our results also confirm that ELC1 and ELC2 interact with MyoA in a mutually exclusive manner and share the same binding site (Fig. 8) , reflecting an emerging theme of redundancy and plasticity in the apicomplexan invasion and motility machinery. In agreement with these results, recent studies have demonstrated that at least one additional myosin contributes to Toxoplasma motility (12, 33) . MyoC localizes to the basal complex of tachyzoites, where it also interacts with ELC1 and MLC1 as well as with GAP proteins and is able to partially compensate for the loss of MyoA by relocalizing along the parasite periphery (33) . Furthermore, deletion of the MyoC gene in tachyzoites that lack MyoA results in greater defects in their ability to glide, invade, and egress, despite not leading to any impairment when MyoC was deleted alone (12, 33) . As ELC1 is now confirmed to associate with both MyoA and MyoC (33) , it is possible that simultaneous removal of ELC1 and ELC2 may in fact disrupt the function of both myosins, potentially explaining why the deletion of both essential light chains leads to a more severe defect in some motilitydependent processes than deletion of MyoA alone (13) . The possibility also remains that either of the two essential light chains could interact with other Toxoplasma myosins and/or other IQ motif-containing proteins, as has been shown previously for human and fly ELCs (34, 35) . In the latter case, the conditional removal of endogenous or introduction of mutant essential light chain presented in this study may also affect unknown cellular processes. The concept of redundancy and plasticity was also recently established in the invasion pathway for the AMA-RON pairs (36) , and, given the redundancy and plasticity of the ELCs shown here, together with that discovered for the glideosome components MyoA/C (12, 33) and GAP45/GAP70/GAP80 (3, 33) , it is likely that a greater level of complexity exists to ensure the production of force for motility in a complex physiological setting. One important difference exists, however, between what we have found with ELC1 and ELC2 and the redundant mechanisms in other components as outlined above. Both ELC1 and ELC2 appear to be associated (in a mutually exclusive manner) with the glideosome under physiological conditions, while other redundant mechanisms have been observed only upon the genetic removal of other components.
Myosin lever arms can be regulated by direct or indirect Ca 2ϩ -dependent mechanisms. The direct interaction of ELCs with Ca 2ϩ is one such method, and the presence of putative EF hands on both ELC1 and ELC2 provided the first insight that the essential light chains may regulate glideosome activity by interacting directly with Ca 2ϩ . We compared structural models containing the two essential light chains and found that, as expected, the Ca 2ϩ -binding regions were conserved. Therefore, we performed a detailed investigation of only a single essential light chain, ELC1. We confirmed that ELC1 has the ability to directly bind Ca 2ϩ in vitro at EFI by using E. coli-expressed wild-type ELC1 in comparison with an EFI mutant. Furthermore, we then investigated the importance of the residues involved in this interaction in vivo by assessing the effect of residue mutation on gliding motility, invasion, and egress. In agreement with our model, disruption of a key residue predicted to coordinate Ca 2ϩ activity impaired all glidingdependent processes tested. Despite these results, a recent convincing report by Bookwalter et al. showed that the presence of Ca 2ϩ had no effect on the speed of in vitro motility of recombinant MyoA-ELC1-MLC1 complexes expressed and purified from insect cells (25) . A possible explanation for these conflicting results is provided by the dissociation constant of ELC1 for Ca 2ϩ determined in Fig. 5F . A Ca 2ϩ dissociation constant of~38 M is low, and if ELC1 can also interact with other divalent cations, EFI could instead be occupied by Mg 2ϩ (Fig 8) , which would be present at a higher concentration than free Ca 2ϩ ions in the cellular environment. The results of replacement of Ca 2ϩ with Mg 2ϩ in the structural model presented here suggest that Mg 2ϩ would behave similarly to Ca 2ϩ . Such an interaction has been proven for MlcD, the light chain of Dictyostelium discoideum MyoD, which has dissociation constants of 52 M for Ca 2ϩ and 450 M for Mg 2ϩ . In cells, MlcD interacts with Mg 2ϩ and myosin motile activity is regulated by the concentration of free Mg 2ϩ ions (37, 38) .
The myosin lever arm is a critical point of rigidity, as the head domain pivots upon ATP hydrolysis to undertake the power stroke for force production and subsequent actin displacement (24, (39) (40) (41) . In this paper, we present the first in vivo functional characterization of the ELCs that complete the MyoA lever arm complex and show their importance for MyoA stability and function. Our structural modeling suggests a possible mechanism for lever arm stabilization whereby Ca 2ϩ binding to ELC1 or ELC2 could facilitate interactions between the two light chains ELC1/ ELC2 and MLC1, thus rigidifying the lever arm region (Fig. 8) . A similar ELC-regulatory light chain (RLC) interface has been shown by Ni et al. to be important for nonmuscle myosin II activity and proposed to be facilitated by phosphorylation of the RLC (42) . We performed a set of functional readouts to test these specific hypotheses related to key interactions between the different lever arm components. Our mutational results confirmed that the key residues predicted to coordinate these interactions contributed to MyoA fidelity in vivo, supporting the idea of a role for the MyoA lever arm in gliding motility. Likewise, in vitro experiments by Bookwalter et al. showed that addition of recombinant ELC1 to a MyoA-MLC1 complex doubled actin filament displacement velocity in vitro (25) , while earlier work demonstrated that deletion of the last 55 C-terminal residues of MyoA completely prevented movement of actin filaments with no detrimental effect on ATPase activity or actin binding capacity shown by the MyoA head (7).
Our report identifies ELC2 and shows the importance of an essential light chain to Toxoplasma gliding motility. Furthermore, it presents an in vivo-validated model of the MyoA lever arm complex, highlighting key residues for lever arm function that are conserved in ELC1 and ELC2 and offering a mechanistic model for how the lever arm is stabilized to perform the power stroke to generate productive motility.
MATERIALS AND METHODS
Cloning of DNA constructs. Refer to Table S1 in the supplemental material for all primer information.
Construction of ELC conditional KOs. The ELC1 and ELC2 conditional KO constructs pPR2-3HA-ELC1 and pPR2-3HA-ELC2 were cre- grid width of 1.2 Å and a fourth-order spline interpolation. Bond lengths were constrained using the LINCS algorithm (49) .
All simulations consisted of an initial minimization of water molecules followed by 200 ps of MD simulations with the protein fixed. After removing all the restraints on the protein, MD simulations were continued for 20 ns. The last 20-ns simulation was analyzed using standard GROMACS tools.
Ca 2ϩ -binding free energies were estimated using the GROMACS umbrella sampling protocol. Starting structures were generated by the use of a pulling simulation using a force constant of 1,000 kJ/(mol nm 2 ) at a rate of 1 nm/ns; the Ca 2ϩ ion was pulled away from its binding pocket (defined by the alpha-carbons of the amino acids of the binding loop), and rotation of the system was prevented using the enforced-rotation function with a force constant of 500 kJ/(mol nm 2 ). A total of 26 structures were selected as umbrella sampling windows. They were equilibrated as described above. A 5-ns simulation was performed in each window for a total simulation time of 130 ns for umbrella sampling. Analysis of results was performed with the weighted-histogram analysis method (WHAM) (50) .
In vitro protein expression and purification. E. coli BL21(DE3) cells were grown in Terrific broth containing 100 g/ml carbenicillin at 37°C to an optical density at 600 nm (OD 600 ) of~0.6, moved at 18°C for 30 min, and induced with 0.2 mM IP for 16 h. The cells were harvested by centrifugation (7,000 ϫ g, 10 min) and stored at Ϫ80°C until needed. To purify ELC1 and the R8A and D15A mutants, cell pellets were resuspended in buffer A (50 mM Tris-HCl [pH 7.5], 300 mM NaCl, 10 mM imidazole, 5 mM 2-mercaptoethanol, and 1 mM phenylmethylsulfonyl fluoride [PMSF] ) and lysed by sonication. Cell debris was removed by centrifugation at 25,000 ϫ g for 30 min and the supernatant applied to a 1-ml bed volume of nickel-nitrilotriacetic acid (Ni-NTA) agarose resin (Qiagen) preequilibrated in buffer A. After washing with 5 column volumes of buffer A was performed, the sample was eluted with buffer supplemented with 100 mM imidazole. The protein was then loaded onto a size exclusion Superdex 200 10/300-Gl column (GE Healthcare) preequilibrated in buffer B (50 mM Tris-HCl [pH 7.5] and 250 mM NaCl), and the peak fractions were pooled, concentrated, and stored at Ϫ80°C after the addition of 20% glycerol.
The purification of the H 6 Ub-MyoA-tail construct was done as follows. The frozen cell pellet was resuspended in buffer C (50 mM Tris-HCl [pH 7.5], 300 mM NaCl, 10 mM imidazole, 10 mM 2-mercaptoethanol, 30% glycerol, and 1 mM PMSF) and lysed by sonication. Unbroken cells and debris were removed by centrifugation at 25,000 ϫ g for 30 min, and the supernatant was applied to a 1-ml bed volume of Ni-NTA agarose resin (Qiagen) preequilibrated in buffer C. After washing of the resin with 5 column volumes of buffer C supplemented with 20 mM imidazole was performed, the protein was eluted in buffer D (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 200 mM imidazole, 1 mM 2-mercaptoethanol, and 30% glycerol). Finally, the protein was loaded onto a size exclusion Superdex 200 column preequilibrated in buffer E (10 mM HEPES [pH 7.4], 150 mM NaCl, 50 M EDTA, and 15% glycerol) and the fractions with the H 6 UbMyoA-tail protein were pooled, snap frozen in liquid nitrogen, and stored at Ϫ80°C until needed.
Thermal shift assay. Binding of Ca 2ϩ to ELC1 and its R8A and D15A mutants was assayed using thermal-shift assays and a Rotor-Gene 3000 real-time PCR machine. The proteins were diluted to a 20 M final concentration in buffer F (50 mM Tris-HCl [pH 7.5] and 50 mM NaCl) containing increasing amounts (10 Ϫ8 to 10 Ϫ3 M) of CaCl 2 in a total reaction volume of 25 l. The fluorescent probe Sypro Orange (Sigma) was diluted 1:100 in dimethyl sulfoxide (DMSO), and 1 l was added per sample just before the run. The temperature was raised in 1°C/min steps from 28°C to 85°C, and fluorescence readings were recorded (excitation, 465 nm; emission, 580 nm). For data analysis, fluorescence was plotted against temperature, and the melting temperature (T m ) of the sample was calculated by fitting the sigmoidal melt curve to the Boltzmann equation as implemented in GraphPad Prism. Data points after the maximum fluorescence intensity were excluded from the fitting. The change in T m as a function of the logarithm of the Ca 2ϩ concentration resulted in a sigmoidal plot, where the half-maximal effective concentration (EC 50 ) was taken to be equal to the Ca 2ϩ affinity (K d [dissociation constant]). Two or more independent titrations were performed for each protein sample.
Egress assay. Parasites were pretreated for 66 h Ϯ 1.0 g/ml ATc and then inoculated onto new s and continued to grow for 30 h with or without ATc and/or 1.0 M shield-1. Egress was stimulated by incubating parasite-infected HFFs with DMEM containing 0.06% DMSO or 8 M Ca 2ϩ ionophore A23187 from Streptomyces chartreusensis (Calbiochem) for 2.5 min at room temperature before fixation with paraformaldehyde (PFA) was performed. IFA was performed as described above with mouse anti-SAG1 antibodies. The average number of ruptured vacuoles was determined by counting a minimum of 100 vacuoles per each slide using duplicate or triplicate slides for each experiment. Three independent experiments were performed. Two-color invasion assay. Parasites were grown in HFF cells for 96 h in the presence and absence of 1.0 g/ml ATc and 1.0 M Shld-1. Freshly lysed parasites were collected and filtered through a 27-gauge needle to release the remaining intracellular parasites. Parasites were counted and adjusted to 2.5 ϫ 10 7 cells/ml in warm DME medium with 10 mM HEPES (pH 7.4). The parasite cell suspension was inoculated onto a new confluent monolayer of HFF cells and grown on glass slides in 24-well plates at 200 l/well in duplicate or triplicate wells. The plate was spun at 1,000 rpm for 1 min to deposit parasites onto the HFF monolayer. Invasion was allowed to proceed for 30 min by incubation at 37°C and 10% CO 2 . After incubation, cells were fixed for 10 min in 2.5% PFA-0.06% glutaraldehyde-HTPBS. A two-color immunofluorescence assay was then performed as described previously (51) . Extracellular parasites were probed with anti-SAG1, and all parasites were stained using anti-GAP45 antibodies. Total numbers of parasites and extracellular parasites were counted for 5 fields of view per slide. Duplicate or triplicate slides were counted for each experiment. Three independent experiments were performed.
Live gliding-motility assay. Freshly egressed parasites were harvested and resuspended in warm Endo buffer (44.7 mM K 2 SO 4 , 10mM MgSO 4 , 106 mM sucrose, 5 mM glucose, 20 mM Tris-H 2 SO 4 , 3.5 mg/ml BSA, pH 8.2) and settled onto glass-bottom culture chamber slides (ibidi) coated with 10 g/ml poly-L lysine-PBS. After the parasites had settled, Endo buffer was slowly aspirated from the chamber and replaced with warm gliding buffer (1 mM EGTA, 20 mM HEPES [pH 7.5], DMEM). Images were collected in 2-s intervals for a minimum of 2 min. Time-lapse video microscopy was conducted using a Zeiss Live Scan microscope equipped with a temperature-controlled chamber to maintain 37°C incubation. Images were collected using phase contrast under conditions of low-light illumination and an AxioCam MR camera at ϫ40 magnification, using AxioVision release 4.8 software to control the shutters and camera. Manual tracking of parasites was achieved with the MTrackJ plugin for ImageJ. Videos were generated using ImageJ software. Motility analyses were performed as reported previously (52) (53) (54) .
Statistical analyses. Graphs were prepared and statistical analyses performed using Prism 6 software. All results are presented as mean values Ϯ standard errors of the means (SEM) of the results of at least 3 independent experiments. Parametric comparisons were tested for statistical significance using unpaired, equal variance, two-tailed Student's t tests. The Mann-Whitney test was used for nonparametric comparisons.
Accession numbers. The EuPathDB gene accession number for the ELC2 sequence presented in this paper is TGME49_305050 (previously TGME49_105050). That for the ELC1 sequence is TGME49_269442 (previously TGME49_069440). 
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